The Biotech Growth Trust (BIOG) Competitors GBX 907 +4.00 (+0.44%) (As of 11:52 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades BIOG vs. LWDB, VEIL, ASHM, EDIN, AGT, GSS, CGT, FCSS, FSV, and JPEShould you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Law Debenture (LWDB), Vietnam Enterprise (VEIL), Ashmore Group (ASHM), Edinburgh Investment (EDIN), AVI Global Trust (AGT), Genesis Emerging Markets Fund (GSS), Capital Gearing (CGT), Fidelity China Special (FCSS), Fidelity Investment Trust - Fidelity Special Values (FSV), and JPMorgan Elect plc - Managed Growth (JPE). These companies are all part of the "asset management" industry. The Biotech Growth Trust vs. Law Debenture Vietnam Enterprise Ashmore Group Edinburgh Investment AVI Global Trust Genesis Emerging Markets Fund Capital Gearing Fidelity China Special Fidelity Investment Trust - Fidelity Special Values JPMorgan Elect plc - Managed Growth The Biotech Growth Trust (LON:BIOG) and Law Debenture (LON:LWDB) are both small-cap financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk. Does the MarketBeat Community prefer BIOG or LWDB? The Biotech Growth Trust received 3 more outperform votes than Law Debenture when rated by MarketBeat users. However, 64.75% of users gave Law Debenture an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote. CompanyUnderperformOutperformThe Biotech Growth TrustOutperform Votes8264.06% Underperform Votes4635.94% Law DebentureOutperform Votes7964.75% Underperform Votes4335.25% Do insiders & institutionals hold more shares of BIOG or LWDB? 28.6% of The Biotech Growth Trust shares are held by institutional investors. Comparatively, 9.3% of Law Debenture shares are held by institutional investors. 0.7% of The Biotech Growth Trust shares are held by company insiders. Comparatively, 6.3% of Law Debenture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, BIOG or LWDB? Law Debenture has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Law Debenture, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Biotech Growth Trust£80.35M3.63£74.60M£2.07438.16Law Debenture£201.31M5.76£140.61M£1.08817.59 Is BIOG or LWDB more profitable? The Biotech Growth Trust has a net margin of 92.85% compared to Law Debenture's net margin of 69.85%. The Biotech Growth Trust's return on equity of 21.57% beat Law Debenture's return on equity.Company Net Margins Return on Equity Return on Assets The Biotech Growth Trust92.85% 21.57% 12.39% Law Debenture 69.85%16.30%8.76% Does the media prefer BIOG or LWDB? In the previous week, Law Debenture had 1 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 1 mentions for Law Debenture and 0 mentions for The Biotech Growth Trust. The Biotech Growth Trust's average media sentiment score of 0.00 equaled Law Debenture'saverage media sentiment score. Company Overall Sentiment The Biotech Growth Trust Neutral Law Debenture Neutral Which has more volatility and risk, BIOG or LWDB? The Biotech Growth Trust has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, Law Debenture has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. SummaryLaw Debenture beats The Biotech Growth Trust on 8 of the 14 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get The Biotech Growth Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOG vs. The Competition Export to ExcelMetricThe Biotech Growth TrustAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£291.42M£812.40M£3.28B£1.39BDividend YieldN/A13.35%4.58%11.76%P/E Ratio438.16772.29441.151,549.26Price / Sales3.6313,881.373,238.98209,640.25Price / Cash87.7480.2548.1732.98Price / Book0.841.701.482.81Net Income£74.60M£57.81M£396.91M£152.92M7 Day Performance-7.83%0.04%0.29%-0.47%1 Month Performance-12.79%-0.49%7.28%7.20%1 Year Performance19.34%10.00%15.63%93.28% The Biotech Growth Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOGThe Biotech Growth TrustN/AGBX 907+0.4%N/A+18.8%£291.42M£80.35M438.16N/ALWDBLaw DebentureN/AGBX 883+1.3%N/A+9.7%£1.16B£201.31M810.37260VEILVietnam EnterpriseN/AGBX 564+2.0%N/A-1.6%£1.15B£-195,880,000.00-610.87N/AHigh Trading VolumeASHMAshmore Group0.2626 of 5 starsGBX 168+1.2%GBX 174+3.6%-6.9%£1.11B£186.80M1,187.14283High Trading VolumeEDINEdinburgh InvestmentN/AGBX 736+1.0%N/A+10.5%£1.10B£141.19M884.34N/AAGTAVI Global TrustN/AGBX 236+1.3%N/A+13.4%£1.07B£137.36M832.14N/AInsider TradeNews CoveragePositive NewsGSSGenesis Emerging Markets FundN/AGBX 869-1.0%N/A+0.0%£1.06B£250.40M6.181,626Gap DownCGTCapital GearingN/AGBX 4,760+0.3%N/A+4.1%£1.02B£-9,860,000.00-7,541.78N/AInsider TradePositive NewsFCSSFidelity China SpecialN/AGBX 211.50+0.5%N/A-3.4%£1.01BN/A4,224.38N/ANews CoveragePositive NewsHigh Trading VolumeFSVFidelity Investment Trust - Fidelity Special ValuesN/AGBX 310+0.6%N/A+10.6%£1.00B£11.88M-30,900.0025,000News CoveragePositive NewsHigh Trading VolumeJPEJPMorgan Elect plc - Managed GrowthN/AGBX 937.50flatN/A+0.0%£1.00B£104.78M1,250.00N/A Related Companies and Tools Related Companies LWDB Alternatives VEIL Alternatives ASHM Alternatives EDIN Alternatives AGT Alternatives GSS Alternatives CGT Alternatives FCSS Alternatives FSV Alternatives JPE Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:BIOG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Biotech Growth Trust PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share The Biotech Growth Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
